Boston Scientific accounts are for healthcare professionals only.
Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.
My Boston Scientific account
Access your online applications and manage your customer profile.
Quick Links
Call customer care
Setting the Standard of Care for LSS
Welcome to the growing network of healthcare providers who can offer patients living with moderate lumbar spinal stenosis (LSS) an opportunity to regain a more active, pain-free lifestyle with the Vertiflex Procedure.
LSS is a biomechanical problem, and patients often find relief by leaning forward or sitting to ease the pressure on nerves in the spine. LSS patients may also experience:
Learn why Rachel Bishop, PA-C started reading her own MRI Imaging, and why she encourages other APPs to do the same.
To confirm moderate degenerative LSS for the Vertiflex Procedure, we must see a 25% to 50% reduction* in the central canal and/or nerve root canal (subarticular, neuroforaminal), compared to adjacent levels on radiographic studies, as per the IFU.
Seera, 74, suffered from pain due to LSS for years.
Watch the story of how Seera found LSS pain relief with the Vertiflex Procedure.
† Superion™ Indirect Decompression System
*Summary of Safety and Effectiveness Data (PMA P140004)
Indications for Use: The Superion™ Indirect Decompression System (IDS) is indicated to treat skeletally mature patients suffering from pain, numbness, and/or cramping in the legs (neurogenic intermittent claudication) secondary to a diagnosis of moderate degenerative lumbar spinal stenosis, with or without Grade 1 spondylolisthesis, having radiographic evidence of thickened ligamentum flavum, narrowed lateral recess, and/or central canal or foraminal narrowing. The Superion™ Interspinous Spacer is indicated for those patients with impaired physical function who experience relief in flexion from symptoms of leg/buttock/groin pain, with or without back pain, who have undergone at least 6 months of non-operative treatment. The Superion Interspinous Spacer may be implanted at one or two adjacent lumbar levels in patients in whom treatment is indicated at no more than two levels, from L1 to L5. Contraindications, warnings, precautions, side effects. The Superion Indirect Decompression System (IDS) is contraindicated for patients who: have spinal anatomy that prevent implantation of the device or cause the device to be unstable in situ (i.e., degenerative spondylolisthesis greater than grade 1), Cauda equina syndrome, or prior decompression or fusion at the index level. Refer to the Instructions for Use provided on www.vertiflex.com for additional Indications for Use, contraindications information and potential adverse effects, warnings, and precautions prior to using this product. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
